Lipella Pharmaceuticals Inc. (LIPO)

CIK 1347242 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lipella Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Jul 15, 20268-K0001753926-26-001173
Mar 31, 20268-K0001753926-26-000577
Feb 4, 20268-K0001753926-26-000265
Nov 14, 202510-Q0001753926-25-001805
Oct 21, 20258-K0001753926-25-001636
Oct 9, 20258-K0001753926-25-001602
Oct 6, 202525-NSE0001354457-25-000985
Sep 18, 20258-K0001753926-25-001525
Aug 14, 202510-Q0001753926-25-001347
Jun 25, 20258-K0001753926-25-001003
Jun 20, 20258-K0001753926-25-000984
Jun 20, 20258-K0001753926-25-000984
Jun 16, 20258-K0001753926-25-000962
Jun 10, 2025PRE 14A0001753926-25-000952
May 16, 20258-K0001753926-25-000856
May 15, 20258-K0001753926-25-000842
May 14, 202510-Q0001753926-25-000818
May 1, 2025SCHEDULE 13G/A0001753926-25-000727
Apr 14, 20258-K0001753926-25-000623
Apr 9, 20258-K0001753926-25-000604
Apr 9, 2025SCHEDULE 13D/A0001753926-25-000614
Apr 9, 2025SCHEDULE 13D/A0001753926-25-000612
Apr 7, 20258-K0001753926-25-000585
Apr 7, 202540001753926-25-000590
Apr 7, 2025SCHEDULE 13D/A0001753926-25-000592